179 related articles for article (PubMed ID: 21152783)
41. Pattern analysis of drug-induced skin diseases.
Justiniano H; Berlingeri-Ramos AC; Sánchez JL
Am J Dermatopathol; 2008 Aug; 30(4):352-69. PubMed ID: 18645307
[TBL] [Abstract][Full Text] [Related]
42. Mucocutaneous side effects of Brequinar sodium. A new inhibitor of pyrimidine de novo biosynthesis.
Schwartsmann G; Bork E; Vermorken JB; Nieboer C; Dodion P; ten Bokkel Huinink WW; Seldenrijk CA; Armand JP; Pinedo HM
Cancer; 1989 Jan; 63(2):243-8. PubMed ID: 2521297
[TBL] [Abstract][Full Text] [Related]
43. Histiocyte-rich dermatoses in two patients with acute lymphocytic leukaemia treated with cytarabine.
Boyd AS
Histopathology; 2004 Aug; 45(2):194-6. PubMed ID: 15279640
[No Abstract] [Full Text] [Related]
44. Adverse cutaneous reactions to psychotropic drugs.
MacMorran WS; Krahn LE
Psychosomatics; 1997; 38(5):413-22. PubMed ID: 9314710
[TBL] [Abstract][Full Text] [Related]
45. Cutaneous drug reactions: pathogenesis and clinical classification.
Wintroub BU; Stern R
J Am Acad Dermatol; 1985 Aug; 13(2 Pt 1):167-79. PubMed ID: 2931455
[TBL] [Abstract][Full Text] [Related]
46. Chemotherapy and cutaneous toxicities: implications for oncology nurses.
Viale PH
Semin Oncol Nurs; 2006 Aug; 22(3):144-51. PubMed ID: 16893743
[TBL] [Abstract][Full Text] [Related]
47. Skin manifestations associated with chemotherapy in children with hematologic malignancies.
Cardoza-Torres MA; Liy-Wong C; Welsh O; Gómez-Flores M; Ocampo-Candiani J; González-Llano O; Gómez-Almaguer D
Pediatr Dermatol; 2012; 29(3):264-9. PubMed ID: 22044286
[TBL] [Abstract][Full Text] [Related]
48. Erlotinib-Associated Rash Exacerbated by Whole-Brain Radiation Therapy: A Patient's Case Report.
Erikson AK; Yu NY; Sheedy JT; Shoudis SN; Paripati HR; Sio TT
Pract Radiat Oncol; 2019 May; 9(3):128-131. PubMed ID: 30770236
[No Abstract] [Full Text] [Related]
49. Cutaneous reactions to chemotherapeutic drugs and targeted therapies for cancer: part I. Conventional chemotherapeutic drugs.
Reyes-Habito CM; Roh EK
J Am Acad Dermatol; 2014 Aug; 71(2):203.e1-203.e12; quiz 215-6. PubMed ID: 25037800
[TBL] [Abstract][Full Text] [Related]
50. Adverse cutaneous reactions to chemotherapeutic agents and cytokine therapy.
Prussick R
Semin Cutan Med Surg; 1996 Dec; 15(4):267-76. PubMed ID: 9069595
[TBL] [Abstract][Full Text] [Related]
51. Cutaneous hemophagocytosis after alemtuzumab injection in a patient with Sézary syndrome.
Jawed SI; Busam K; Wang X; Horwitz S; Querfeld C
JAMA Dermatol; 2014 Sep; 150(9):1021-3. PubMed ID: 25029560
[No Abstract] [Full Text] [Related]
52. Chemotherapy and keratinocytes.
Henry LB; Horn TD
J Cutan Pathol; 2002 Nov; 29(10):575-8. PubMed ID: 12453293
[No Abstract] [Full Text] [Related]
53. Acquired Perforating Dermatosis Induced by PD-1 Inhibitor: A Case Report.
Liu X; Wang H; Wan Y; Guo Y; Shan SJ
Am J Dermatopathol; 2021 Dec; 43(12):942-944. PubMed ID: 34291739
[TBL] [Abstract][Full Text] [Related]
54. [Drug eruptions caused by beta-blockers].
Bonnetblanc JM
Ann Med Interne (Paris); 1984; 135(8):639-41. PubMed ID: 6152136
[TBL] [Abstract][Full Text] [Related]
55. Clinical Management of Cutaneous Adverse Events in Patients on Chemotherapy: A National Consensus Statement by the Spanish Academy of Dermatology and Venereology and the Spanish Society of Medical Oncology.
Sanmartín O; Beato C; Suh-Oh HJ; Aragón I; España A; Majem M; Segura S; Gúrpide A; Botella R; Grávalos C
Actas Dermosifiliogr (Engl Ed); 2019; 110(6):448-459. PubMed ID: 31010573
[TBL] [Abstract][Full Text] [Related]
56. Clinical and histopathologic correlation of an eruption secondary to Taxotere.
Beer K; Oakley H
J Drugs Dermatol; 2010 Dec; 9(12):1534-5. PubMed ID: 21120264
[TBL] [Abstract][Full Text] [Related]
57. Imatinib mesylate and dermatology part 2: a review of the cutaneous side effects of imatinib mesylate.
Scheinfeld N
J Drugs Dermatol; 2006 Mar; 5(3):228-31. PubMed ID: 16573254
[TBL] [Abstract][Full Text] [Related]
58. Cutaneous adverse events associated with heparin.
Maldonado Cid P; Alonso de Celada RM; Noguera Morel L; Feito-Rodríguez M; Gómez-Fernández C; Herranz Pinto P
Clin Exp Dermatol; 2012 Oct; 37(7):707-11. PubMed ID: 22998541
[TBL] [Abstract][Full Text] [Related]
59. [Adverse cutaneous reactions to antidepressants].
Braham C; Paquet P; Pitchot W; Piérard-Franchimont C; Piérard GE
Rev Med Liege; 2003 Jan; 58(1):22-4. PubMed ID: 12647594
[TBL] [Abstract][Full Text] [Related]
60. Cutaneous adverse effects of targeted therapies: Part I: Inhibitors of the cellular membrane.
Macdonald JB; Macdonald B; Golitz LE; LoRusso P; Sekulic A
J Am Acad Dermatol; 2015 Feb; 72(2):203-18; quiz 219-20. PubMed ID: 25592338
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
